Glenn's career spans commercial and clinical roles across the healthcare industry, with expertise in building and turning around biotech and pharma organizations. He began at Allergan, advancing through key roles and developing strong ties with thought leaders. At Biogen, he directed business units in dermatology and neurology (MS), followed by Merz Pharmaceuticals, where he built Merz Canada from the ground up and achieved record-breaking profitability. Later, as VP and Head of Neuroscience for Merz North America, Glenn revitalized a struggling team and drove robust growth. Since 2017, he has also advised biotech startups and led BD efforts at Stiris Research, a CRO focused on oncology and neuroscience.Now, as President and co-founder of Synap Biotech, Glenn is leading innovative efforts in neuroregenerative therapies aimed at transforming stroke and neurological recovery.
Listed skills include Pharmaceutical Industry, Pharmaceutical Sales, Oncology, Dermatology, and 15 others.